0      0

24th Napa Pain Conference

NPC2017-Sa09a - Improving Safety for Neuromodulation & Intrathecal Therapy: The Neuromodulation Appropriateness Committee & Polyanalgesic Consensus Conference Recommendations

Aug 19, 2017 4:30pm ‐ Aug 19, 2017 6:15pm

Credits: None available.



It is of paramount importance that clinicians who manage implantable pain therapies (neuromodulation and intrathecal drug delivery systems) understand treatment risks and methods to modify those risks to improve outcomes.


4:30 Infection Prevention & Control: David A. Provenzano, MD
5:00 Anticoagulation Therapy Management for Implantable Therapies: B. Todd Sitzman, MD, MPH
5:30 Safety Guidelines for the Reduction of Severe Neurological Injury: Peter S. Staats, MD, MBA
6:00 Q&A: All


As a result of completing this course, learners will be able/ better able to:

  • Employ techniques to reduce the risks of surgical site infection.
  • Reduce the risks of neurological injury associated with implanted neurostimulation and intrathecal pumps.
  • Apply anticoagulation therapies to interventional pain procedures.


  • Narouze S, Benzon HT, Provenzano DA, Buvanendran A, De Andres J, Deer TR, Rauck R, Huntoon MA: Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the american society of regional anesthesia and pain medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Regional Anesthesia and Pain Medicine 2015; 40: 182-212
  • Provenzano DA, Deer T, Luginbuhl Phelps A, Drennen ZC, Thomson S, Hayek SM, Narouze S, Rana MV, Watson TW, Buvanendran A: An International Survey to Understand Infection Control Practices for Spinal Cord Stimulation. Neuromodulation 201


Category: CME


Credits: None available.

You must be logged in and own this session in order to post comments.